Monthly Archives: February 2010

Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study

CONTRIBUTORS: Joseph Biederman, MD,a Michael C. Monuteaux, ScD,a Thomas Spencer, MD,a Timothy E. Wilens, MD,a and Stephen V. Faraone, PhDb c

WHAT’S KNOWN ON THIS SUBJECT: Treatment with stimulants has been shown to improve the core symptoms of ADHD and remain the mainstay of its treatment. However, a recent study found that stimulant therapy protected youth with ADHD against the subsequent development of MD.
WHAT THIS STUDY ADDS: This study provides novel evidence that stimulant treatment may be protective against the subsequent development of adverse psychopathological and educational outcomes. These findings could assist clinicians in treatment planning and forecasting prognosis for youth with ADHD.

OBJECTIVE: Little is known about the effect of stimulant treatment in youth with attention-deficit/hyperactivity disorder (ADHD) on the subsequent development of comorbid psychiatric disorders. We tested the association between stimulant treatment and the subsequent development of psychiatric comorbidity in a longitudinal sample of patients
with ADHD.
METHODS: We conducted a case-control, 10-year prospective follow-up study into young-adult years of youth with ADHD. At baseline, we assessed consecutively referred white male children with (n140) and without (n  120) ADHD, aged 6 to 18 years. At the 10-year follow-up, 112 (80%) and 105 (88%) of the children in the ADHD and control groups, respectively, were reassessed (mean age: 22 years). We examined the association between stimulant treatment in childhood and adolescence and subsequent comorbid disorders and grade retention by using proportional hazards survival models.
RESULTS: Of the 112 participants with ADHD, 82 (73%) were previously treated with stimulants. Participants with ADHD who were treated with stimulants were significantly less likely to subsequently develop depressive and anxiety disorders and disruptive behavior and less likely to repeat a grade compared with participants with ADHD who were not treated.
CONCLUSIONS: We found evidence that stimulant treatment decreases the risk for subsequent comorbid psychiatric disorders and academic failure in youth with ADHD. Pediatrics 2009;124:71–78

ADHD Summer Camp 2010

Camp dates:  June 14th – August 6th
Time:  8:30 – 4:30 – 5:00 Mon – Fri
Location:  SLC, UT

Refer to for additional detail about the camp program